{
  "frames":[
    {
      "text":"Matrix-bound VEGF",
      "frame-id":"evem-PMC2828913-UAZ-r1-3-0-1",
      "arguments":[
        {
          "text":"Matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-3-0-3"
        },
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-3-0-4"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-3",
        "offset":17,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-3",
        "offset":0,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-3-0",
      "verbose-text":"Matrix bound VEGF elicits more distinct vascular effects than soluble VEGF , including prolonged VEGFR2 activation with altered patterns of tyrosine activation and downstream enhancement of the p38 and MAPK pathway .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"matrix-bound VEGF",
      "frame-id":"evem-PMC2828913-UAZ-r1-5-2-2",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-5-2-14"
        },
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-5-2-15"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-5",
        "offset":445,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-5",
        "offset":428,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-5-2",
      "verbose-text":"Exposure of endothelial cells to matrix bound VEGF elicits prolonged activation of VEGFR2 with differential phosphorylation of Y1214 , and extended activation kinetics of p38 .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"matrix-bound VEGF",
      "frame-id":"evem-PMC2828913-UAZ-r1-5-2-3",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-5-2-14"
        },
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-5-2-15"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-5",
        "offset":445,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-5",
        "offset":428,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-5-2",
      "verbose-text":"Exposure of endothelial cells to matrix bound VEGF elicits prolonged activation of VEGFR2 with differential phosphorylation of Y1214 , and extended activation kinetics of p38 .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-5-5-4",
      "text":"beta1 integrin blocks the prolonged phosphorylation of Y1214 and consequent activation of p38",
      "arguments":[
        {
          "text":"p38",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controlled",
          "arg":"ment-PMC2828913-UAZ-r1-5-5-27"
        },
        {
          "text":"beta1 integrin",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controller",
          "arg":"ment-PMC2828913-UAZ-r1-5-5-25"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-5",
        "offset":922,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-5",
        "offset":829,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-5-5",
      "found-by":"Negative_activation_syntax_1_verb",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"Inactivation of beta1 integrin blocks the prolonged phosphorylation of Y1214 and consequent activation of p38 ."
    },
    {
      "text":"Matrix-bound VEGF",
      "frame-id":"evem-PMC2828913-UAZ-r1-5-4-5",
      "arguments":[
        {
          "text":"Matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-5-4-21"
        },
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-5-4-22"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-5",
        "offset":652,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-5",
        "offset":635,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-5-4",
      "verbose-text":"Matrix bound VEGF also promotes reciprocal responses on beta1 integrin by inducing its association with focal adhesions ; a response that is absent upon exposure to soluble VEGF .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-5-2-6",
      "text":"matrix-bound VEGF elicits prolonged activation of VEGFR2",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controlled",
          "arg":"ment-PMC2828913-UAZ-r1-5-2-16"
        },
        {
          "text":"matrix-bound VEGF",
          "argument-type":"complex",
          "object-type":"argument",
          "index":0,
          "argument-label":"controller",
          "args":{
            "theme1":"ment-PMC2828913-UAZ-r1-5-2-14",
            "theme2":"ment-PMC2828913-UAZ-r1-5-2-15"
          }
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-5",
        "offset":484,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-5",
        "offset":428,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-5-2",
      "found-by":"Positive_activation_syntax_1_verb",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"Exposure of endothelial cells to matrix bound VEGF elicits prolonged activation of VEGFR2 with differential phosphorylation of Y1214 , and extended activation kinetics of p38 ."
    },
    {
      "text":"matrix-bound VEGF",
      "frame-id":"evem-PMC2828913-UAZ-r1-5-1-7",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-5-1-11"
        },
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-5-1-12"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-5",
        "offset":318,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-5",
        "offset":301,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-5-1",
      "verbose-text":"Here , we show molecular distinctions between signaling initiated from soluble versus matrix bound VEGF , which mediates a sustained level of VEGFR2 internalization and clustering .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"Binding of VEGFR2 to VEGF",
      "frame-id":"evem-PMC2828913-UAZ-r1-10-3-8",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-10-3-45"
        },
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-10-3-46"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-10",
        "offset":656,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-10",
        "offset":631,
        "object-type":"relative-pos"
      },
      "found-by":"binding3",
      "sentence":"sent-PMC2828913-UAZ-r1-10-3",
      "verbose-text":"Binding of VEGFR2 to VEGF induces dimerization and consequent phosphorylation of a subset of intracellular tyrosine residues                       .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"matrix-bound VEGF",
      "frame-id":"evem-PMC2828913-UAZ-r1-12-10-9",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-12-10-78"
        },
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-12-10-79"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-12",
        "offset":1803,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-12",
        "offset":1786,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-12-10",
      "verbose-text":"Here , we demonstrate that matrix bound VEGF induces prolonged activation kinetics of VEGFR2 with altered patterns of tyrosine activation and subsequent downstream enhancement of the p38 and MAPK pathway .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"VEGF bound to the ECM",
      "frame-id":"evem-PMC2828913-UAZ-r1-12-7-10",
      "arguments":[
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-12-7-75"
        },
        {
          "text":"ECM",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-12-7-76"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-12",
        "offset":1435,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-12",
        "offset":1414,
        "object-type":"relative-pos"
      },
      "found-by":"binding1b",
      "sentence":"sent-PMC2828913-UAZ-r1-12-7",
      "verbose-text":"These in vivo results highlighted the notion that VEGF bound to the ECM is bioactive , confirming earlier findings in vitro                    .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"matrix-bound VEGF",
      "frame-id":"evem-PMC2828913-UAZ-r1-12-10-11",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-12-10-78"
        },
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-12-10-79"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-12",
        "offset":1803,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-12",
        "offset":1786,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-12-10",
      "verbose-text":"Here , we demonstrate that matrix bound VEGF induces prolonged activation kinetics of VEGFR2 with altered patterns of tyrosine activation and subsequent downstream enhancement of the p38 and MAPK pathway .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-12-10-12",
      "text":"matrix-bound VEGF induces prolonged activation kinetics of VEGFR2",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controlled",
          "arg":"ment-PMC2828913-UAZ-r1-12-10-80"
        },
        {
          "text":"matrix-bound VEGF",
          "argument-type":"complex",
          "object-type":"argument",
          "index":0,
          "argument-label":"controller",
          "args":{
            "theme1":"ment-PMC2828913-UAZ-r1-12-10-78",
            "theme2":"ment-PMC2828913-UAZ-r1-12-10-79"
          }
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-12",
        "offset":1851,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-12",
        "offset":1786,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-12-10",
      "found-by":"Positive_activation_syntax_1_verb",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"Here , we demonstrate that matrix bound VEGF induces prolonged activation kinetics of VEGFR2 with altered patterns of tyrosine activation and subsequent downstream enhancement of the p38 and MAPK pathway ."
    },
    {
      "text":"their binding to extracellular matrix (ECM",
      "frame-id":"evem-PMC2828913-UAZ-r1-12-3-13",
      "arguments":[
        {
          "text":"mouse VEGF164",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-12-2-64"
        },
        {
          "text":"ECM",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-12-3-66"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-12",
        "offset":468,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-12",
        "offset":426,
        "object-type":"relative-pos"
      },
      "found-by":"corefCardinality",
      "sentence":"sent-PMC2828913-UAZ-r1-12-3",
      "verbose-text":"These isoforms differ in their binding to extracellular matrix ( ECM ) molecules by virtue of the extent of the C-terminal region beyond the receptor binding domain                              .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"their binding to extracellular matrix (ECM",
      "frame-id":"evem-PMC2828913-UAZ-r1-12-3-14",
      "arguments":[
        {
          "text":"mouse VEGF120",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-12-2-63"
        },
        {
          "text":"ECM",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-12-3-66"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-12",
        "offset":468,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-12",
        "offset":426,
        "object-type":"relative-pos"
      },
      "found-by":"corefCardinality",
      "sentence":"sent-PMC2828913-UAZ-r1-12-3",
      "verbose-text":"These isoforms differ in their binding to extracellular matrix ( ECM ) molecules by virtue of the extent of the C-terminal region beyond the receptor binding domain                              .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"matrix-bound VEGF165",
      "frame-id":"evem-PMC2828913-UAZ-r1-18-2-15",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-18-2-117"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-18-2-118"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-18",
        "offset":338,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-18",
        "offset":318,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-18-2",
      "verbose-text":"We found that matrix bound VEGF165 induced phosphorylation of VEGFR2 at equivalent levels as of soluble VEGF165 at 5 min                      .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"matrix-bound VEGF165",
      "frame-id":"evem-PMC2828913-UAZ-r1-18-5-16",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-18-5-126"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-18-5-127"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-18",
        "offset":788,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-18",
        "offset":768,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-18-5",
      "verbose-text":"Activation of VEGFR2 by matrix bound VEGF165 was reproduced using multiple primary endothelial cell types and with two commercial sources of VEGF165                  .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"matrix-bound VEGF165",
      "frame-id":"evem-PMC2828913-UAZ-r1-18-6-17",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-18-6-130"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-18-6-131"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-18",
        "offset":969,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-18",
        "offset":949,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-18-6",
      "verbose-text":"Furthermore , lower concentrations of matrix bound VEGF165 than soluble VEGF165 were sufficient to induce phosphorylation of VEGFR2           .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-18-2-18",
      "text":"phosphorylation of VEGFR2",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-18-2-119"
        }
      ],
      "type":"protein-modification",
      "frame-type":"event-mention",
      "subtype":"phosphorylation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-18",
        "offset":372,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-18",
        "offset":347,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-18-2",
      "found-by":"Phosphorylation_syntax_1_noun",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"We found that matrix bound VEGF165 induced phosphorylation of VEGFR2 at equivalent levels as of soluble VEGF165 at 5 min                      ."
    },
    {
      "is-hypothesis":true,
      "frame-id":"evem-PMC2828913-UAZ-r1-18-0-19",
      "text":"matrix-bound VEGF165",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-18-0-110"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-18-0-111"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-18",
        "offset":44,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-18",
        "offset":24,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-18-0",
      "found-by":"binding_token_3",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"Next , we tested whether matrix bound VEGF165 ( Vb ) remained active by evaluating its ability to phosphorylate VEGFR2 when compared with soluble VEGF165 ( Vs ) at identical concentrations for 5 min ."
    },
    {
      "text":"matrix-bound VEGF165",
      "frame-id":"evem-PMC2828913-UAZ-r1-18-6-20",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-18-6-130"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-18-6-131"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-18",
        "offset":969,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-18",
        "offset":949,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-18-6",
      "verbose-text":"Furthermore , lower concentrations of matrix bound VEGF165 than soluble VEGF165 were sufficient to induce phosphorylation of VEGFR2           .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-18-6-21",
      "text":"phosphorylation of VEGFR2",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-18-6-133"
        }
      ],
      "type":"protein-modification",
      "frame-type":"event-mention",
      "subtype":"phosphorylation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-18",
        "offset":1042,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-18",
        "offset":1017,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-18-6",
      "found-by":"Phosphorylation_syntax_1_noun",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"Furthermore , lower concentrations of matrix bound VEGF165 than soluble VEGF165 were sufficient to induce phosphorylation of VEGFR2           ."
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-18-0-22",
      "text":"phosphorylate VEGFR2",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-18-0-113"
        }
      ],
      "type":"protein-modification",
      "frame-type":"event-mention",
      "subtype":"phosphorylation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-18",
        "offset":115,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-18",
        "offset":95,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-18-0",
      "found-by":"Phosphorylation_syntax_1_verb",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"Next , we tested whether matrix bound VEGF165 ( Vb ) remained active by evaluating its ability to phosphorylate VEGFR2 when compared with soluble VEGF165 ( Vs ) at identical concentrations for 5 min ."
    },
    {
      "text":"matrix-bound VEGF165",
      "frame-id":"evem-PMC2828913-UAZ-r1-18-2-23",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-18-2-117"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-18-2-118"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-18",
        "offset":338,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-18",
        "offset":318,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-18-2",
      "verbose-text":"We found that matrix bound VEGF165 induced phosphorylation of VEGFR2 at equivalent levels as of soluble VEGF165 at 5 min                      .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-18-5-24",
      "text":"Activation of VEGFR2 by matrix-bound VEGF165",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controlled",
          "arg":"ment-PMC2828913-UAZ-r1-18-5-125"
        },
        {
          "text":"matrix-bound VEGF165",
          "argument-type":"complex",
          "object-type":"argument",
          "index":0,
          "argument-label":"controller",
          "args":{
            "theme1":"ment-PMC2828913-UAZ-r1-18-5-126",
            "theme2":"ment-PMC2828913-UAZ-r1-18-5-127"
          }
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-18",
        "offset":788,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-18",
        "offset":744,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-18-5",
      "found-by":"Positive_activation_token_2_noun",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"Activation of VEGFR2 by matrix bound VEGF165 was reproduced using multiple primary endothelial cell types and with two commercial sources of VEGF165                  ."
    },
    {
      "text":"matrix-bound VEGF165",
      "frame-id":"evem-PMC2828913-UAZ-r1-18-5-25",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-18-5-126"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-18-5-127"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-18",
        "offset":788,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-18",
        "offset":768,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-18-5",
      "verbose-text":"Activation of VEGFR2 by matrix bound VEGF165 was reproduced using multiple primary endothelial cell types and with two commercial sources of VEGF165                  .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"matrix-bound VEGF165",
      "frame-id":"evem-PMC2828913-UAZ-r1-20-1-26",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-20-1-139"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-20-1-140"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-20",
        "offset":131,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-20",
        "offset":111,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-20-1",
      "verbose-text":"( A ) Confluent PAE-KDR cultures were exposed for 5 min to matrix bound VEGF165 ( Vb ) , soluble VEGF165 ( Vs ; 100 ng and ml and 200 ng and ml ) , vehicle only ( - ) , or polymerized collagen gels .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "is-hypothesis":true,
      "frame-id":"evem-PMC2828913-UAZ-r1-20-7-27",
      "text":"VEGFR2 phosphorylation",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-20-7-149"
        }
      ],
      "type":"protein-modification",
      "frame-type":"event-mention",
      "subtype":"phosphorylation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-20",
        "offset":765,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-20",
        "offset":743,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-20-7",
      "found-by":"Phosphorylation_syntax_4_noun",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"( D ) VEGFR2 phosphorylation was induced by different concentrations of Vs or Vb , as indicated ."
    },
    {
      "text":"matrix-bound VEGF165",
      "frame-id":"evem-PMC2828913-UAZ-r1-20-12-28",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-20-12-161"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-20-12-162"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-20",
        "offset":1286,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-20",
        "offset":1266,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-20-12",
      "verbose-text":"( F ) HUVECs exposed to either soluble ( 200 ng and ml ) or matrix bound VEGF165 and at the indicated times .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-20-2-29",
      "text":"VEGFR2 (210 kD) phosphorylation",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-20-2-144"
        }
      ],
      "type":"protein-modification",
      "frame-type":"event-mention",
      "subtype":"phosphorylation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-20",
        "offset":273,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-20",
        "offset":242,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-20-2",
      "found-by":"Phosphorylation_token_8_noun",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"Level of VEGFR2 ( 210 kD ) phosphorylation was determined by Western blot analysis using a pan-phosphotyrosine antibody ( 4G10 ) ."
    },
    {
      "text":"Matrix-bound VEGF165",
      "frame-id":"evem-PMC2828913-UAZ-r1-20-0-30",
      "arguments":[
        {
          "text":"Matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-20-0-136"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-20-0-137"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-20",
        "offset":20,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-20",
        "offset":0,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-20-0",
      "verbose-text":"Matrix bound VEGF165 is able to phosphorylate VEGFR2 .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-20-0-31",
      "text":"phosphorylate VEGFR2",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-20-0-138"
        }
      ],
      "type":"protein-modification",
      "frame-type":"event-mention",
      "subtype":"phosphorylation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-20",
        "offset":52,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-20",
        "offset":32,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-20-0",
      "found-by":"Phosphorylation_syntax_1_verb",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"Matrix bound VEGF165 is able to phosphorylate VEGFR2 ."
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-20-14-32",
      "text":"phosphorylation of VEGFR2",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-20-14-166"
        }
      ],
      "type":"protein-modification",
      "frame-type":"event-mention",
      "subtype":"phosphorylation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-20",
        "offset":1451,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-20",
        "offset":1426,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-20-14",
      "found-by":"Phosphorylation_syntax_1_noun",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"Note that prolonged phosphorylation of VEGFR2 in bound when compared with soluble VEGF165 ."
    },
    {
      "text":"Matrix-bound VEGF165",
      "frame-id":"evem-PMC2828913-UAZ-r1-22-0-33",
      "arguments":[
        {
          "text":"Matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-22-0-169"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-22-0-170"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-22",
        "offset":20,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-22",
        "offset":0,
        "object-type":"relative-pos"
      },
      "found-by":"binding1b",
      "sentence":"sent-PMC2828913-UAZ-r1-22-0",
      "verbose-text":"Matrix bound VEGF165 increases kinetics of VEGFR2 activation and mediates clustering of the receptor",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-22-0-34",
      "text":"Matrix-bound VEGF165 increases kinetics of VEGFR2",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controlled",
          "arg":"ment-PMC2828913-UAZ-r1-22-0-171"
        },
        {
          "text":"Matrix-bound VEGF165",
          "argument-type":"complex",
          "object-type":"argument",
          "index":0,
          "argument-label":"controller",
          "args":{
            "theme1":"ment-PMC2828913-UAZ-r1-22-0-169",
            "theme2":"ment-PMC2828913-UAZ-r1-22-0-170"
          }
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-22",
        "offset":49,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-22",
        "offset":0,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-22-0",
      "found-by":"Positive_activation_syntax_5_noun",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"Matrix bound VEGF165 increases kinetics of VEGFR2 activation and mediates clustering of the receptor"
    },
    {
      "text":"Matrix-bound VEGF165",
      "frame-id":"evem-PMC2828913-UAZ-r1-22-0-35",
      "arguments":[
        {
          "text":"Matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-22-0-169"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-22-0-170"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-22",
        "offset":20,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-22",
        "offset":0,
        "object-type":"relative-pos"
      },
      "found-by":"binding1b",
      "sentence":"sent-PMC2828913-UAZ-r1-22-0",
      "verbose-text":"Matrix bound VEGF165 increases kinetics of VEGFR2 activation and mediates clustering of the receptor",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"Matrix-bound VEGF165 increases kinetics of VEGFR2",
      "frame-id":"evem-PMC2828913-UAZ-r1-22-0-36",
      "arguments":[
        {
          "text":"Matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-22-0-169"
        },
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-22-0-171"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-22",
        "offset":49,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-22",
        "offset":0,
        "object-type":"relative-pos"
      },
      "found-by":"binding_syntax_23_verb",
      "sentence":"sent-PMC2828913-UAZ-r1-22-0",
      "verbose-text":"Matrix bound VEGF165 increases kinetics of VEGFR2 activation and mediates clustering of the receptor",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"VEGF165 bound to matrix",
      "frame-id":"evem-PMC2828913-UAZ-r1-23-1-37",
      "arguments":[
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-23-1-180"
        },
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-23-1-181"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-23",
        "offset":438,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-23",
        "offset":415,
        "object-type":"relative-pos"
      },
      "found-by":"binding1b",
      "sentence":"sent-PMC2828913-UAZ-r1-23-1",
      "verbose-text":"Activation of VEGFR2 did not require the release of VEGF from matrix , as presence of broad-spectrum matrix metalloproteinases and plasmin inhibitors showed identical results                      , further supporting the conclusion that VEGF165 bound to matrix can induce activation of VEGFR2 .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"matrix-bound VEGF165",
      "frame-id":"evem-PMC2828913-UAZ-r1-24-3-38",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-24-3-192"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-24-3-193"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-24",
        "offset":476,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-24",
        "offset":456,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-24-3",
      "verbose-text":"Exposure of confluent cells to either soluble or matrix bound VEGF165 induced a broader distribution of VEGFR2 to the periphery of the cell and , in the case of matrix bound VEGF165 , it also resulted in formation of large clusters that were less predominant in cells treated with soluble VEGF165                  .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-24-3-39",
      "text":"matrix-bound VEGF165 induced a broader distribution of VEGFR2",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controlled",
          "arg":"ment-PMC2828913-UAZ-r1-24-3-194"
        },
        {
          "text":"matrix-bound VEGF165",
          "argument-type":"complex",
          "object-type":"argument",
          "index":0,
          "argument-label":"controller",
          "args":{
            "theme1":"ment-PMC2828913-UAZ-r1-24-3-192",
            "theme2":"ment-PMC2828913-UAZ-r1-24-3-193"
          }
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-24",
        "offset":517,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-24",
        "offset":456,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-24-3",
      "found-by":"Positive_activation_syntax_1_verb",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"Exposure of confluent cells to either soluble or matrix bound VEGF165 induced a broader distribution of VEGFR2 to the periphery of the cell and , in the case of matrix bound VEGF165 , it also resulted in formation of large clusters that were less predominant in cells treated with soluble VEGF165                  ."
    },
    {
      "text":"matrix-bound VEGF165",
      "frame-id":"evem-PMC2828913-UAZ-r1-24-3-40",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-24-3-192"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-24-3-193"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-24",
        "offset":476,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-24",
        "offset":456,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-24-3",
      "verbose-text":"Exposure of confluent cells to either soluble or matrix bound VEGF165 induced a broader distribution of VEGFR2 to the periphery of the cell and , in the case of matrix bound VEGF165 , it also resulted in formation of large clusters that were less predominant in cells treated with soluble VEGF165                  .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"matrix-bound VEGF165",
      "frame-id":"evem-PMC2828913-UAZ-r1-24-0-41",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-24-0-183"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-24-0-184"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-24",
        "offset":53,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-24",
        "offset":33,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-24-0",
      "verbose-text":"To further explore the effect of matrix bound VEGF165 on receptor function , we examined the extracellular distribution of receptors upon activation by Vs and Vb .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"matrix-bound VEGF165",
      "frame-id":"evem-PMC2828913-UAZ-r1-24-3-42",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-24-3-196"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-24-3-197"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-24",
        "offset":587,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-24",
        "offset":567,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-24-3",
      "verbose-text":"Exposure of confluent cells to either soluble or matrix bound VEGF165 induced a broader distribution of VEGFR2 to the periphery of the cell and , in the case of matrix bound VEGF165 , it also resulted in formation of large clusters that were less predominant in cells treated with soluble VEGF165                  .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"matrix-bound VEGF",
      "frame-id":"evem-PMC2828913-UAZ-r1-24-1-43",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-24-1-187"
        },
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-24-1-188"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-24",
        "offset":193,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-24",
        "offset":176,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-24-1",
      "verbose-text":"We found that matrix bound VEGF induced receptor clustering at the cell surface                  .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"matrix-bound VEGF165",
      "frame-id":"evem-PMC2828913-UAZ-r1-26-0-44",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-26-0-200"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-26-0-201"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-26",
        "offset":81,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-26",
        "offset":61,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-26-0",
      "verbose-text":"VEGFR2 clustering and internalization induced by soluble and matrix bound VEGF165 .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"VEGFR2 clustering and internalization induced by soluble and matrix-bound VEGF165",
      "frame-id":"evem-PMC2828913-UAZ-r1-26-0-45",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-26-0-199"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-26-0-201"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-26",
        "offset":81,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-26",
        "offset":0,
        "object-type":"relative-pos"
      },
      "found-by":"binding1b",
      "sentence":"sent-PMC2828913-UAZ-r1-26-0",
      "verbose-text":"VEGFR2 clustering and internalization induced by soluble and matrix bound VEGF165 .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"matrix-bound VEGF165",
      "frame-id":"evem-PMC2828913-UAZ-r1-26-0-46",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-26-0-200"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-26-0-201"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-26",
        "offset":81,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-26",
        "offset":61,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-26-0",
      "verbose-text":"VEGFR2 clustering and internalization induced by soluble and matrix bound VEGF165 .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-26-0-47",
      "text":"VEGFR2 clustering and internalization induced by soluble and matrix-bound VEGF165",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controlled",
          "arg":"ment-PMC2828913-UAZ-r1-26-0-199"
        },
        {
          "text":"matrix-bound VEGF165",
          "argument-type":"complex",
          "object-type":"argument",
          "index":0,
          "argument-label":"controller",
          "args":{
            "theme1":"ment-PMC2828913-UAZ-r1-26-0-200",
            "theme2":"ment-PMC2828913-UAZ-r1-26-0-201"
          }
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-26",
        "offset":81,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-26",
        "offset":0,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-26-0",
      "found-by":"Positive_activation_syntax_2_verb",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"VEGFR2 clustering and internalization induced by soluble and matrix bound VEGF165 ."
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-27-6-48",
      "text":"VEGFR2 phosphorylation",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-27-6-249"
        }
      ],
      "type":"protein-modification",
      "frame-type":"event-mention",
      "subtype":"phosphorylation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-27",
        "offset":1165,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-27",
        "offset":1143,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-27-6",
      "found-by":"Phosphorylation_syntax_4_noun",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"We found that endocytosis was required for VEGFR2 phosphorylation under both bound and soluble conditions           ."
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-27-3-49",
      "text":"VEGFR2 internalization and phosphorylation",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-27-3-245"
        }
      ],
      "type":"protein-modification",
      "frame-type":"event-mention",
      "subtype":"phosphorylation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-27",
        "offset":736,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-27",
        "offset":694,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-27-3",
      "found-by":"Phosphorylation_syntax_4_noun",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"To further ascertain the relationship between VEGFR2 internalization and phosphorylation , we investigated whether internalized VEGR2 remained phosphorylated using pan-phosphotyrosine antibodies           ."
    },
    {
      "text":"Matrix-bound VEGF",
      "frame-id":"evem-PMC2828913-UAZ-r1-29-0-50",
      "arguments":[
        {
          "text":"Matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-29-0-250"
        },
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-29-0-251"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-29",
        "offset":17,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-29",
        "offset":0,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-29-0",
      "verbose-text":"Matrix bound VEGF leads to prolonged activation of Y1214 on VEGFR2",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-30-3-51",
      "text":"phosphorylation of VEGFR2",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-30-3-266"
        }
      ],
      "type":"protein-modification",
      "frame-type":"event-mention",
      "subtype":"phosphorylation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-30",
        "offset":724,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-30",
        "offset":699,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-30-3",
      "found-by":"Phosphorylation_syntax_1_noun",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"Initially , a pan-phosphotyrosine antibody ( 4G10 ) showed overall phosphorylation of VEGFR2 under both conditions            at 5 and 15 min ."
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-30-4-52",
      "text":"phosphorylation of VEGFR2",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-30-4-267"
        }
      ],
      "type":"protein-modification",
      "frame-type":"event-mention",
      "subtype":"phosphorylation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-30",
        "offset":841,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-30",
        "offset":816,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-30-4",
      "found-by":"Phosphorylation_syntax_1_noun",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"As shown in                , a prolonged phosphorylation of VEGFR2 was frequently noted in the context of Vb treatment ."
    },
    {
      "text":"HEK 293 cell lines expressing Y1214F VEGFR2 mutant were incubated with soluble (Vs; 200 ng/ml) or bound VEGF165",
      "frame-id":"evem-PMC2828913-UAZ-r1-32-5-53",
      "arguments":[
        {
          "text":"HEK",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-32-5-282"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-32-5-285"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-32",
        "offset":634,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-32",
        "offset":523,
        "object-type":"relative-pos"
      },
      "found-by":"binding_17",
      "sentence":"sent-PMC2828913-UAZ-r1-32-5",
      "verbose-text":"( C ) HEK 293 cell lines expressing Y1214F VEGFR2 mutant were incubated with soluble ( Vs ; 200 ng and ml ) or bound VEGF165 ( Vb ) for 5 min and 15 min , vehicle ( - ) , or collagen only ( col ) for 5 min .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"HEK 293 cell lines expressing Y1214F VEGFR2 mutant were incubated with soluble (Vs; 200 ng/ml) or bound VEGF165 (Vb) for 5 min and 15 min, vehicle (-), or collagen",
      "frame-id":"evem-PMC2828913-UAZ-r1-32-5-54",
      "arguments":[
        {
          "text":"HEK",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-32-5-282"
        },
        {
          "text":"collagen",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-32-5-287"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-32",
        "offset":686,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-32",
        "offset":523,
        "object-type":"relative-pos"
      },
      "found-by":"binding_17",
      "sentence":"sent-PMC2828913-UAZ-r1-32-5",
      "verbose-text":"( C ) HEK 293 cell lines expressing Y1214F VEGFR2 mutant were incubated with soluble ( Vs ; 200 ng and ml ) or bound VEGF165 ( Vb ) for 5 min and 15 min , vehicle ( - ) , or collagen only ( col ) for 5 min .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"matrix-bound VEGF165 is specific to tyrosine 1214",
      "frame-id":"evem-PMC2828913-UAZ-r1-32-0-55",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-32-0-269"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-32-0-270"
        },
        {
          "text":"tyrosine 1214",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"site",
          "arg":"ment-PMC2828913-UAZ-r1-32-0-271"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-32",
        "offset":86,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-32",
        "offset":37,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-32-0",
      "verbose-text":"Prolonged phosphorylation induced by matrix bound VEGF165 is specific to tyrosine 1214 .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"matrix-bound VEGF165",
      "frame-id":"evem-PMC2828913-UAZ-r1-33-2-56",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-33-2-303"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-33-2-304"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-33",
        "offset":522,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-33",
        "offset":502,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-33-2",
      "verbose-text":"By 15 min , while most phosphorylation sites had returned to baseline , Y1214 showed a substantial retention of activation exclusively by matrix bound VEGF165 and was gradually back to baseline levels only after 30 min            .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"matrix-bound VEGF165",
      "frame-id":"evem-PMC2828913-UAZ-r1-33-1-57",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-33-1-298"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-33-1-299"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-33",
        "offset":213,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-33",
        "offset":193,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-33-1",
      "verbose-text":"At 5 min , Y951 appeared to be preferentially phosphorylated by matrix bound VEGF165 ; however , this residue was quickly dephosphorylated ( at 15 min ) and could not explain the prolonged phosphorylation induced by matrix anchored VEGF165 .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"matrix-bound VEGF",
      "frame-id":"evem-PMC2828913-UAZ-r1-34-2-58",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-34-2-318"
        },
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-34-2-319"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-34",
        "offset":468,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-34",
        "offset":451,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-34-2",
      "verbose-text":"Only the Y1214 mutation abrogated the increased levels of phosphorylation on VEGFR2 upon exposure to matrix bound VEGF .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-34-3-59",
      "text":"phosphorylation of VEGFR2",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-34-3-322"
        }
      ],
      "type":"protein-modification",
      "frame-type":"event-mention",
      "subtype":"phosphorylation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-34",
        "offset":597,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-34",
        "offset":572,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-34-3",
      "found-by":"Phosphorylation_syntax_1_noun",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"These findings further support the concept that matrix bound VEGF leads to a temporal increase in the phosphorylation of VEGFR2 , and that this occurs through Y1214 ."
    },
    {
      "text":"matrix-bound VEGF",
      "frame-id":"evem-PMC2828913-UAZ-r1-34-3-60",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-34-3-320"
        },
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-34-3-321"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-34",
        "offset":535,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-34",
        "offset":518,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-34-3",
      "verbose-text":"These findings further support the concept that matrix bound VEGF leads to a temporal increase in the phosphorylation of VEGFR2 , and that this occurs through Y1214 .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"Matrix-bound VEGF165",
      "frame-id":"evem-PMC2828913-UAZ-r1-36-0-61",
      "arguments":[
        {
          "text":"Matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-36-0-324"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-36-0-325"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-36",
        "offset":20,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-36",
        "offset":0,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-36-0",
      "verbose-text":"Matrix bound VEGF165 leads to higher activation of the p38 and MAPK pathway",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"matrix-bound VEGF165",
      "frame-id":"evem-PMC2828913-UAZ-r1-37-1-62",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-37-1-331"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-37-1-332"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-37",
        "offset":236,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-37",
        "offset":216,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-37-1",
      "verbose-text":"Indeed , we found that matrix bound VEGF165 mediates higher and sustained activation of p38           .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"matrix-bound VEGF165",
      "frame-id":"evem-PMC2828913-UAZ-r1-37-4-63",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-37-4-338"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-37-4-339"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-37",
        "offset":604,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-37",
        "offset":584,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-37-4",
      "verbose-text":"To better understand the overall effect of matrix bound VEGF165 , we conducted a protein antibody array analysis on nearly 40 common downstream signaling molecules , including all the major signaling pathways activated downstream of VEGFR2 , such as MAPK , p38 , PI3K , and Akt ( unpublished data ) .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-37-2-64",
      "text":"p38 phosphorylation",
      "arguments":[
        {
          "text":"p38",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-37-2-334"
        }
      ],
      "type":"protein-modification",
      "frame-type":"event-mention",
      "subtype":"phosphorylation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-37",
        "offset":338,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-37",
        "offset":319,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-37-2",
      "found-by":"Phosphorylation_syntax_4_noun",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"Moreover , kinetics of p38 phosphorylation correlated with the activation kinetics of pY1214 ."
    },
    {
      "text":"matrix-bound VEGF165",
      "frame-id":"evem-PMC2828913-UAZ-r1-39-1-65",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-39-1-361"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-39-1-362"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-39",
        "offset":195,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-39",
        "offset":175,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-39-1",
      "verbose-text":"( A ) Confluent HUVEC cultures were incubated in the presence or absence of soluble ( Vs ) or matrix bound VEGF165 ( Vb ; 200 ng and ml ) for 5 min .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"matrix-bound VEGF165",
      "frame-id":"evem-PMC2828913-UAZ-r1-39-0-66",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-39-0-359"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-39-0-360"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-39",
        "offset":83,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-39",
        "offset":63,
        "object-type":"relative-pos"
      },
      "found-by":"binding1b",
      "sentence":"sent-PMC2828913-UAZ-r1-39-0",
      "verbose-text":"p38 and Akt pathways are differentially induced by soluble and matrix bound VEGF165 .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-41-0-67",
      "text":"VEGF isoforms that lack matrix-retention domains do not support prolonged activation of VEGFR2",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controlled",
          "arg":"ment-PMC2828913-UAZ-r1-41-0-374"
        },
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controller",
          "arg":"ment-PMC2828913-UAZ-r1-41-0-373"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "is-negated":true,
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-41",
        "offset":94,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-41",
        "offset":0,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-41-0",
      "found-by":"Positive_activation_syntax_1_verb",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"VEGF isoforms that lack matrix-retention domains do not support prolonged activation of VEGFR2"
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-42-1-68",
      "text":"VEGF113 or VEGF121 failed to elicit activation of VEGFR2",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controlled",
          "arg":"ment-PMC2828913-UAZ-r1-42-1-387"
        },
        {
          "text":"VEGF113",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controller",
          "arg":"ment-PMC2828913-UAZ-r1-42-1-385"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "is-negated":true,
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-42",
        "offset":331,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-42",
        "offset":275,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-42-1",
      "found-by":"Positive_activation_syntax_1_verb",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"Collagen polymerized with VEGF113 or VEGF121 failed to elicit activation of VEGFR2 , in contrast to their ability to activate the same receptor when presented in a soluble form ."
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-42-1-69",
      "text":"VEGF121 failed to elicit activation of VEGFR2",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controlled",
          "arg":"ment-PMC2828913-UAZ-r1-42-1-387"
        },
        {
          "text":"VEGF121",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controller",
          "arg":"ment-PMC2828913-UAZ-r1-42-1-386"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "is-negated":true,
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-42",
        "offset":331,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-42",
        "offset":286,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-42-1",
      "found-by":"Positive_activation_syntax_1_verb",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"Collagen polymerized with VEGF113 or VEGF121 failed to elicit activation of VEGFR2 , in contrast to their ability to activate the same receptor when presented in a soluble form ."
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-42-0-70",
      "text":"phosphorylate of VEGFR2, Y1214",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-42-0-381"
        },
        {
          "text":"Y1214",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"site",
          "arg":"ment-PMC2828913-UAZ-r1-42-0-382"
        }
      ],
      "type":"protein-modification",
      "frame-type":"event-mention",
      "subtype":"phosphorylation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-42",
        "offset":220,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-42",
        "offset":190,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-42-0",
      "found-by":"Phosphorylation_syntax_3_verb",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"To further test the relevance of matrix anchorage on activation of p38 , we tested VEGF121 and VEGF113 ( isoforms lacking ECM binding domain ) polymerized on collagen gels for their ability to phosphorylate of VEGFR2 , Y1214 , and p38                  ."
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-42-0-71",
      "text":"phosphorylate of VEGFR2, Y1214, and p38",
      "arguments":[
        {
          "text":"p38",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-42-0-383"
        },
        {
          "text":"Y1214",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"site",
          "arg":"ment-PMC2828913-UAZ-r1-42-0-382"
        }
      ],
      "type":"protein-modification",
      "frame-type":"event-mention",
      "subtype":"phosphorylation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-42",
        "offset":229,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-42",
        "offset":190,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-42-0",
      "found-by":"Phosphorylation_syntax_3_verb",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"To further test the relevance of matrix anchorage on activation of p38 , we tested VEGF121 and VEGF113 ( isoforms lacking ECM binding domain ) polymerized on collagen gels for their ability to phosphorylate of VEGFR2 , Y1214 , and p38                  ."
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-44-8-72",
      "text":"VEGFR2 activation by VEGF",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controlled",
          "arg":"ment-PMC2828913-UAZ-r1-44-8-404"
        },
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controller",
          "arg":"ment-PMC2828913-UAZ-r1-44-8-405"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-44",
        "offset":796,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-44",
        "offset":771,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-44-8",
      "found-by":"Positive_activation_syntax_2_noun",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"( D ) Dose curve of VEGFR2 activation by VEGF ."
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-47-0-73",
      "text":"activation of VEGFR2 by Vb",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controlled",
          "arg":"ment-PMC2828913-UAZ-r1-47-0-421"
        },
        {
          "text":"Vb",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controller",
          "arg":"ment-PMC2828913-UAZ-r1-47-0-422"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-47",
        "offset":36,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-47",
        "offset":10,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-47-0",
      "found-by":"Positive_activation_token_2_noun",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"Prolonged activation of VEGFR2 by Vb is not due to local concentration of VEGF165"
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-48-7-74",
      "text":"VEGFR2 phosphorylation",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-48-7-439"
        }
      ],
      "type":"protein-modification",
      "frame-type":"event-mention",
      "subtype":"phosphorylation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-48",
        "offset":1191,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-48",
        "offset":1169,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-48-7",
      "found-by":"Phosphorylation_token_3_noun",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"Therefore , the differences in VEGFR2 phosphorylation kinetics induced by Vb were not the product of changes in VEGF stability ."
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-48-5-75",
      "text":"VEGFR2 phosphorylation",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-48-5-436"
        }
      ],
      "type":"protein-modification",
      "frame-type":"event-mention",
      "subtype":"phosphorylation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-48",
        "offset":923,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-48",
        "offset":901,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-48-5",
      "found-by":"Phosphorylation_token_3_noun",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"VEGF165 concentrations above 150 ng and ml resulted in the same VEGFR2 phosphorylation kinetics , indicating that the receptors were saturated at this concentration ."
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-48-4-76",
      "text":"VEGFR2 phosphorylation",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-48-4-433"
        }
      ],
      "type":"protein-modification",
      "frame-type":"event-mention",
      "subtype":"phosphorylation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-48",
        "offset":683,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-48",
        "offset":661,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-48-4",
      "found-by":"Phosphorylation_syntax_4_noun",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"Yet , to further support the conclusions , we performed an additional assessment of VEGFR2 phosphorylation using soluble VEGF165 at higher concentrations and examined whether these conditions would change the kinetics of receptor activation                      ."
    },
    {
      "text":"Matrix-bound VEGF165",
      "frame-id":"evem-PMC2828913-UAZ-r1-50-0-77",
      "arguments":[
        {
          "text":"Matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-50-0-448"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-50-0-449"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-50",
        "offset":20,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-50",
        "offset":0,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-50-0",
      "verbose-text":"Matrix bound VEGF165 induces association of VEGFR2 with beta1 integrin and promotes redistribution of this integrin to focal adhesions",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-50-0-78",
      "text":"Matrix-bound VEGF165 induces association of VEGFR2 with beta1 integrin and promotes redistribution of this integrin",
      "arguments":[
        {
          "text":"integrin",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controlled",
          "arg":"ment-PMC2828913-UAZ-r1-50-0-452"
        },
        {
          "text":"Matrix-bound VEGF165",
          "argument-type":"complex",
          "object-type":"argument",
          "index":0,
          "argument-label":"controller",
          "args":{
            "theme1":"ment-PMC2828913-UAZ-r1-50-0-448",
            "theme2":"ment-PMC2828913-UAZ-r1-50-0-449"
          }
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-50",
        "offset":115,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-50",
        "offset":0,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-50-0",
      "found-by":"Positive_activation_syntax_1_verb",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"Matrix bound VEGF165 induces association of VEGFR2 with beta1 integrin and promotes redistribution of this integrin to focal adhesions"
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-50-0-79",
      "text":"Matrix-bound VEGF165 induces association of VEGFR2",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controlled",
          "arg":"ment-PMC2828913-UAZ-r1-50-0-450"
        },
        {
          "text":"Matrix-bound VEGF165",
          "argument-type":"complex",
          "object-type":"argument",
          "index":0,
          "argument-label":"controller",
          "args":{
            "theme1":"ment-PMC2828913-UAZ-r1-50-0-448",
            "theme2":"ment-PMC2828913-UAZ-r1-50-0-449"
          }
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-50",
        "offset":50,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-50",
        "offset":0,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-50-0",
      "found-by":"Positive_activation_syntax_1_verb",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"Matrix bound VEGF165 induces association of VEGFR2 with beta1 integrin and promotes redistribution of this integrin to focal adhesions"
    },
    {
      "text":"Matrix-bound VEGF165",
      "frame-id":"evem-PMC2828913-UAZ-r1-50-0-80",
      "arguments":[
        {
          "text":"Matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-50-0-448"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-50-0-449"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-50",
        "offset":20,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-50",
        "offset":0,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-50-0",
      "verbose-text":"Matrix bound VEGF165 induces association of VEGFR2 with beta1 integrin and promotes redistribution of this integrin to focal adhesions",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"VEGFR2/beta1 integrin interactions",
      "frame-id":"evem-PMC2828913-UAZ-r1-53-6-81",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-53-6-490"
        },
        {
          "text":"beta1 integrin",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-53-6-491"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-53",
        "offset":720,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-53",
        "offset":686,
        "object-type":"relative-pos"
      },
      "found-by":"binding7a",
      "sentence":"sent-PMC2828913-UAZ-r1-53-6",
      "verbose-text":"Red dots denote regions of signal amplification consistent with VEGFR2 and beta1 integrin interactions .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"matrix-bound VEGF165",
      "frame-id":"evem-PMC2828913-UAZ-r1-54-3-82",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-54-3-500"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-54-3-501"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-54",
        "offset":373,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-54",
        "offset":353,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-54-3",
      "verbose-text":"We also found that matrix bound VEGF165 induces redistribution of beta1 integrins to focal adhesions                  .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-54-3-83",
      "text":"matrix-bound VEGF165 induces redistribution of beta1 integrins",
      "arguments":[
        {
          "text":"beta1 integrins",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controlled",
          "arg":"ment-PMC2828913-UAZ-r1-54-3-502"
        },
        {
          "text":"matrix-bound VEGF165",
          "argument-type":"complex",
          "object-type":"argument",
          "index":0,
          "argument-label":"controller",
          "args":{
            "theme1":"ment-PMC2828913-UAZ-r1-54-3-500",
            "theme2":"ment-PMC2828913-UAZ-r1-54-3-501"
          }
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-54",
        "offset":415,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-54",
        "offset":353,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-54-3",
      "found-by":"Positive_activation_syntax_1_verb",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"We also found that matrix bound VEGF165 induces redistribution of beta1 integrins to focal adhesions                  ."
    },
    {
      "text":"matrix-bound VEGF165",
      "frame-id":"evem-PMC2828913-UAZ-r1-54-3-84",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-54-3-500"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-54-3-501"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-54",
        "offset":373,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-54",
        "offset":353,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-54-3",
      "verbose-text":"We also found that matrix bound VEGF165 induces redistribution of beta1 integrins to focal adhesions                  .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"matrix-bound VEGF165",
      "frame-id":"evem-PMC2828913-UAZ-r1-56-0-85",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-56-0-507"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-56-0-508"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-56",
        "offset":87,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-56",
        "offset":67,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-56-0",
      "verbose-text":"beta1 integrin redistributes to focal adhesion upon stimulation by matrix bound VEGF165 .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"matrix-bound VEGF165",
      "frame-id":"evem-PMC2828913-UAZ-r1-59-2-86",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-59-2-532"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-59-2-533"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-59",
        "offset":428,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-59",
        "offset":408,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-59-2",
      "verbose-text":"Furthermore , prolonged phosphorylation of VEGFR2-Y1214 induced by matrix bound VEGF165 at 15 min was no longer detected if the cells were pretreated with beta1 integrin inhibitory antibodies           .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"matrix-bound VEGF",
      "frame-id":"evem-PMC2828913-UAZ-r1-59-3-87",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-59-3-537"
        },
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-59-3-538"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-59",
        "offset":620,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-59",
        "offset":603,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-59-3",
      "verbose-text":"The association of VEGFR2 and beta1 integrin triggered by matrix bound VEGF was also disrupted when beta1 integrins were blocked           .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-59-2-88",
      "text":"phosphorylation of VEGFR2-Y1214",
      "arguments":[
        {
          "text":"VEGFR2-Y1214",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-59-2-531"
        }
      ],
      "type":"protein-modification",
      "frame-type":"event-mention",
      "subtype":"phosphorylation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-59",
        "offset":396,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-59",
        "offset":365,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-59-2",
      "found-by":"Phosphorylation_syntax_1_noun",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"Furthermore , prolonged phosphorylation of VEGFR2-Y1214 induced by matrix bound VEGF165 at 15 min was no longer detected if the cells were pretreated with beta1 integrin inhibitory antibodies           ."
    },
    {
      "text":"matrix-bound VEGF165",
      "frame-id":"evem-PMC2828913-UAZ-r1-59-0-89",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-59-0-526"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-59-0-527"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-59",
        "offset":106,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-59",
        "offset":86,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-59-0",
      "verbose-text":"The contribution of beta1 integrins to the prolonged responses of p38 and Y1214 under matrix bound VEGF165 treatment was challenged by beta1 integrin inhibitory antibodies .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-59-1-90",
      "text":"phosphorylation of p38",
      "arguments":[
        {
          "text":"p38",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-59-1-529"
        }
      ],
      "type":"protein-modification",
      "frame-type":"event-mention",
      "subtype":"phosphorylation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-59",
        "offset":265,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-59",
        "offset":243,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-59-1",
      "found-by":"Phosphorylation_syntax_1_noun",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"Pretreatment of cultures with inhibitory antibodies blocked prolonged phosphorylation of p38 that now was equivalent to treatment with soluble VEGF165 alone           ."
    },
    {
      "text":"matrix-bound VEGF",
      "frame-id":"evem-PMC2828913-UAZ-r1-59-3-91",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-59-3-537"
        },
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-59-3-538"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-59",
        "offset":620,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-59",
        "offset":603,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-59-3",
      "verbose-text":"The association of VEGFR2 and beta1 integrin triggered by matrix bound VEGF was also disrupted when beta1 integrins were blocked           .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"matrix-bound VEGF165",
      "frame-id":"evem-PMC2828913-UAZ-r1-59-2-92",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-59-2-532"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-59-2-533"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-59",
        "offset":428,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-59",
        "offset":408,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-59-2",
      "verbose-text":"Furthermore , prolonged phosphorylation of VEGFR2-Y1214 induced by matrix bound VEGF165 at 15 min was no longer detected if the cells were pretreated with beta1 integrin inhibitory antibodies           .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-59-3-93",
      "text":"VEGFR2 and beta1 integrin triggered by matrix-bound VEGF",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controlled",
          "arg":"ment-PMC2828913-UAZ-r1-59-3-535"
        },
        {
          "text":"matrix-bound VEGF",
          "argument-type":"complex",
          "object-type":"argument",
          "index":0,
          "argument-label":"controller",
          "args":{
            "theme1":"ment-PMC2828913-UAZ-r1-59-3-537",
            "theme2":"ment-PMC2828913-UAZ-r1-59-3-538"
          }
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-59",
        "offset":620,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-59",
        "offset":564,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-59-3",
      "found-by":"Positive_activation_syntax_2_verb",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"The association of VEGFR2 and beta1 integrin triggered by matrix bound VEGF was also disrupted when beta1 integrins were blocked           ."
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-59-3-94",
      "text":"beta1 integrin triggered by matrix-bound VEGF",
      "arguments":[
        {
          "text":"beta1 integrin",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controlled",
          "arg":"ment-PMC2828913-UAZ-r1-59-3-536"
        },
        {
          "text":"matrix-bound VEGF",
          "argument-type":"complex",
          "object-type":"argument",
          "index":0,
          "argument-label":"controller",
          "args":{
            "theme1":"ment-PMC2828913-UAZ-r1-59-3-537",
            "theme2":"ment-PMC2828913-UAZ-r1-59-3-538"
          }
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-59",
        "offset":620,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-59",
        "offset":575,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-59-3",
      "found-by":"Positive_activation_syntax_2_verb",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"The association of VEGFR2 and beta1 integrin triggered by matrix bound VEGF was also disrupted when beta1 integrins were blocked           ."
    },
    {
      "text":"pY1214 and P38 of matrix-bound VEGF165",
      "frame-id":"evem-PMC2828913-UAZ-r1-61-0-95",
      "arguments":[
        {
          "text":"pY1214",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-61-0-544"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-61-0-547"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-61",
        "offset":84,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-61",
        "offset":46,
        "object-type":"relative-pos"
      },
      "found-by":"binding_syntax_23_verb",
      "sentence":"sent-PMC2828913-UAZ-r1-61-0",
      "verbose-text":"Blocking beta1 integrin dampens activation of pY1214 and P38 of matrix bound VEGF165 .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"P38 of matrix-bound VEGF165",
      "frame-id":"evem-PMC2828913-UAZ-r1-61-0-96",
      "arguments":[
        {
          "text":"P38",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-61-0-545"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-61-0-547"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-61",
        "offset":84,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-61",
        "offset":57,
        "object-type":"relative-pos"
      },
      "found-by":"binding_syntax_23_verb",
      "sentence":"sent-PMC2828913-UAZ-r1-61-0",
      "verbose-text":"Blocking beta1 integrin dampens activation of pY1214 and P38 of matrix bound VEGF165 .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"matrix-bound VEGF165",
      "frame-id":"evem-PMC2828913-UAZ-r1-61-0-97",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-61-0-546"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-61-0-547"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-61",
        "offset":84,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-61",
        "offset":64,
        "object-type":"relative-pos"
      },
      "found-by":"binding_syntax_23_verb",
      "sentence":"sent-PMC2828913-UAZ-r1-61-0",
      "verbose-text":"Blocking beta1 integrin dampens activation of pY1214 and P38 of matrix bound VEGF165 .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"matrix-bound VEGF165",
      "frame-id":"evem-PMC2828913-UAZ-r1-62-5-98",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-62-5-582"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-62-5-583"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-62",
        "offset":854,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-62",
        "offset":834,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-62-5",
      "verbose-text":"In agreement with previous findings , only matrix bound VEGF165 led to prolonged phosphorylation of Y1214 in wild-type MLECs after 15 min of treatment , whereas both soluble and bound VEGF165 resulted in equivalent activation of Y1175 .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-62-10-99",
      "text":"VEGFR2 was phosphorylated",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-62-10-596"
        }
      ],
      "type":"protein-modification",
      "frame-type":"event-mention",
      "subtype":"phosphorylation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-62",
        "offset":1638,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-62",
        "offset":1613,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-62-10",
      "found-by":"Phosphorylation_syntax_2_verb",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"Interestingly , albeit reduced , VEGFR2 was phosphorylated but unable to support prolonged activation of p38 in the absence of beta1 integrin           ."
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-62-10-100",
      "text":"VEGFR2 was phosphorylated but unable to support prolonged activation of p38",
      "arguments":[
        {
          "text":"p38",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controlled",
          "arg":"ment-PMC2828913-UAZ-r1-62-10-597"
        },
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controller",
          "arg":"ment-PMC2828913-UAZ-r1-62-10-596"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-62",
        "offset":1688,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-62",
        "offset":1613,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-62-10",
      "found-by":"Positive_activation_syntax_1_verb",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"Interestingly , albeit reduced , VEGFR2 was phosphorylated but unable to support prolonged activation of p38 in the absence of beta1 integrin           ."
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-62-0-101",
      "text":"phosphorylation of VEGFR2",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-62-0-572"
        }
      ],
      "type":"protein-modification",
      "frame-type":"event-mention",
      "subtype":"phosphorylation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-62",
        "offset":98,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-62",
        "offset":73,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-62-0",
      "found-by":"Phosphorylation_syntax_1_noun",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"We further determined the contribution of beta1 integrin to the specific phosphorylation of VEGFR2 using genetic loss-of-function experiments ."
    },
    {
      "text":"matrix-bound VEGF",
      "frame-id":"evem-PMC2828913-UAZ-r1-63-0-102",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-63-0-601"
        },
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-63-0-602"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-63",
        "offset":126,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-63",
        "offset":109,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-63-0",
      "verbose-text":"Together , these findings support the conclusion that association of beta1 integrin with VEGFR2 is induced by matrix bound VEGF and it is critical for the prolonged phosphorylation responses found specifically in Y1214 and downstream activation of the p38 MAPK pathway .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"VEGFR2 and clustering induced by matrix-bound VEGF165",
      "frame-id":"evem-PMC2828913-UAZ-r1-65-0-103",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-65-0-606"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-65-0-608"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-65",
        "offset":117,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-65",
        "offset":64,
        "object-type":"relative-pos"
      },
      "found-by":"binding_syntax_23_verb",
      "sentence":"sent-PMC2828913-UAZ-r1-65-0",
      "verbose-text":"beta1 integrin is required for the prolonged internalization of VEGFR2 and clustering induced by matrix bound VEGF165",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"matrix-bound VEGF165",
      "frame-id":"evem-PMC2828913-UAZ-r1-65-0-104",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-65-0-607"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-65-0-608"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-65",
        "offset":117,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-65",
        "offset":97,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-65-0",
      "verbose-text":"beta1 integrin is required for the prolonged internalization of VEGFR2 and clustering induced by matrix bound VEGF165",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"Matrix-bound VEGF",
      "frame-id":"evem-PMC2828913-UAZ-r1-68-12-105",
      "arguments":[
        {
          "text":"Matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-68-12-643"
        },
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-68-12-644"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-68",
        "offset":1352,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-68",
        "offset":1335,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-68-12",
      "verbose-text":"Matrix bound VEGF ( right ) interacts easily with receptors as the cells migrate into the matrix .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"matrix-bound VEGF",
      "frame-id":"evem-PMC2828913-UAZ-r1-68-10-106",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-68-10-638"
        },
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-68-10-639"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-68",
        "offset":1232,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-68",
        "offset":1215,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-68-10",
      "verbose-text":"( C ) Schematic model depicting the interaction of soluble and matrix bound VEGF with VEGFR2 .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"binding between integrins and VEGFR2",
      "frame-id":"evem-PMC2828913-UAZ-r1-68-14-107",
      "arguments":[
        {
          "text":"integrins",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-68-14-649"
        },
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-68-14-650"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-68",
        "offset":1647,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-68",
        "offset":1611,
        "object-type":"relative-pos"
      },
      "found-by":"binding_20",
      "sentence":"sent-PMC2828913-UAZ-r1-68-14",
      "verbose-text":"Over time , the progressive recruitment of integrins facilitates clustering of VEGFR2 and results in binding between integrins and VEGFR2 .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "is-hypothesis":true,
      "frame-id":"evem-PMC2828913-UAZ-r1-69-0-108",
      "text":"matrix-bound VEGF",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-69-0-652"
        },
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-69-0-653"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-69",
        "offset":70,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-69",
        "offset":53,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-69-0",
      "found-by":"binding_token_3",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"Based on these findings , we propose a model in which matrix bound VEGF progressively facilitates proximity and subsequent binding to beta1 integrins           ."
    },
    {
      "text":"matrix-bound VEGF",
      "frame-id":"evem-PMC2828913-UAZ-r1-72-4-109",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-72-4-671"
        },
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-72-4-672"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-72",
        "offset":1075,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-72",
        "offset":1058,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-72-4",
      "verbose-text":"These effects are dependent on beta1 integrin , as pharmacological or genetic inactivation of this molecule suppressed the differential signaling events initiated by matrix bound VEGF .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"Matrix-bound VEGF",
      "frame-id":"evem-PMC2828913-UAZ-r1-72-3-110",
      "arguments":[
        {
          "text":"Matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-72-3-667"
        },
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-72-3-668"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-72",
        "offset":703,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-72",
        "offset":686,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-72-3",
      "verbose-text":"Matrix bound VEGF induces receptor clustering , association with beta1 integrin , and the initiation of a pro-migratory phenotype on endothelial cells that is reminiscent of tip cells                        .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"it covalently bound to the matrix",
      "frame-id":"evem-PMC2828913-UAZ-r1-73-1-111",
      "arguments":[
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-73-1-681"
        },
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-73-1-682"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-73",
        "offset":207,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-73",
        "offset":174,
        "object-type":"relative-pos"
      },
      "found-by":"corefCardinality",
      "sentence":"sent-PMC2828913-UAZ-r1-73-1",
      "verbose-text":"Studies using modified VEGF to make it covalently bound to the matrix have shown that under those conditions , VEGF can lead to increase proliferation of endothelial cells                                        .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "is-hypothesis":true,
      "frame-id":"evem-PMC2828913-UAZ-r1-73-0-112",
      "text":"Activation of VEGF receptors by VEGF",
      "arguments":[
        {
          "text":"VEGF receptors",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controlled",
          "arg":"ment-PMC2828913-UAZ-r1-73-0-678"
        },
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controller",
          "arg":"ment-PMC2828913-UAZ-r1-73-0-679"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-73",
        "offset":36,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-73",
        "offset":0,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-73-0",
      "found-by":"Positive_activation_syntax_2_noun",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"Activation of VEGF receptors by VEGF in the context of matrix has been previously noted , but not fully characterized                    ."
    },
    {
      "is-hypothesis":true,
      "frame-id":"evem-PMC2828913-UAZ-r1-73-0-113",
      "text":"Activation of VEGF receptors by VEGF in the context of matrix",
      "arguments":[
        {
          "text":"VEGF receptors",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controlled",
          "arg":"ment-PMC2828913-UAZ-r1-73-0-678"
        },
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controller",
          "arg":"ment-PMC2828913-UAZ-r1-73-0-680"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-73",
        "offset":61,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-73",
        "offset":0,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-73-0",
      "found-by":"Positive_activation_syntax_1_noun",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"Activation of VEGF receptors by VEGF in the context of matrix has been previously noted , but not fully characterized                    ."
    },
    {
      "is-hypothesis":true,
      "frame-id":"evem-PMC2828913-UAZ-r1-73-0-114",
      "text":"Activation of VEGF receptors by VEGF in the context of matrix",
      "arguments":[
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controlled",
          "arg":"ment-PMC2828913-UAZ-r1-73-0-677"
        },
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controller",
          "arg":"ment-PMC2828913-UAZ-r1-73-0-680"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-73",
        "offset":61,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-73",
        "offset":0,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-73-0",
      "found-by":"Positive_activation_syntax_1_noun",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"Activation of VEGF receptors by VEGF in the context of matrix has been previously noted , but not fully characterized                    ."
    },
    {
      "text":"matrix-bound VEGF",
      "frame-id":"evem-PMC2828913-UAZ-r1-75-5-115",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-75-5-715"
        },
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-75-5-716"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-75",
        "offset":796,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-75",
        "offset":779,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-75-5",
      "verbose-text":"Nonetheless , we found that matrix bound VEGF significantly increased the ratio of beta1 integrin associated with activated VEGFR2 in a time dependent manner , with maximum phosphorylation at 15 min and still clearly detectable by 30 min .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"matrix-bound VEGF",
      "frame-id":"evem-PMC2828913-UAZ-r1-75-5-116",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-75-5-715"
        },
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-75-5-716"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-75",
        "offset":796,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-75",
        "offset":779,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-75-5",
      "verbose-text":"Nonetheless , we found that matrix bound VEGF significantly increased the ratio of beta1 integrin associated with activated VEGFR2 in a time dependent manner , with maximum phosphorylation at 15 min and still clearly detectable by 30 min .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"beta1 integrin associated with activated VEGFR2",
      "frame-id":"evem-PMC2828913-UAZ-r1-75-5-117",
      "arguments":[
        {
          "text":"beta1 integrin",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-75-5-717"
        },
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-75-5-718"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-75",
        "offset":881,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-75",
        "offset":834,
        "object-type":"relative-pos"
      },
      "found-by":"binding10b",
      "sentence":"sent-PMC2828913-UAZ-r1-75-5",
      "verbose-text":"Nonetheless , we found that matrix bound VEGF significantly increased the ratio of beta1 integrin associated with activated VEGFR2 in a time dependent manner , with maximum phosphorylation at 15 min and still clearly detectable by 30 min .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-75-6-118",
      "text":"phosphorylation of VEGFR2-Y1214",
      "arguments":[
        {
          "text":"VEGFR2-Y1214",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-75-6-719"
        }
      ],
      "type":"protein-modification",
      "frame-type":"event-mention",
      "subtype":"phosphorylation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-75",
        "offset":1112,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-75",
        "offset":1081,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-75-6",
      "found-by":"Phosphorylation_syntax_1_noun",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"This association was biologically significant and necessary for the selective and continued phosphorylation of VEGFR2-Y1214 and for the increase in p38 ."
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-75-7-119",
      "text":"VEGF induced redistribution of beta1 integrin",
      "arguments":[
        {
          "text":"beta1 integrin",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controlled",
          "arg":"ment-PMC2828913-UAZ-r1-75-7-723"
        },
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controller",
          "arg":"ment-PMC2828913-UAZ-r1-75-7-722"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "is-negated":true,
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-75",
        "offset":1229,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-75",
        "offset":1184,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-75-7",
      "found-by":"Positive_activation_syntax_1_verb",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"Furthermore , matrix bound but not soluble VEGF induced redistribution of beta1 integrin to focal adhesions ."
    },
    {
      "text":"binding of VEGFR2 to beta3 integrin",
      "frame-id":"evem-PMC2828913-UAZ-r1-75-3-120",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-75-3-710"
        },
        {
          "text":"beta3 integrin",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-75-3-711"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-75",
        "offset":460,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-75",
        "offset":425,
        "object-type":"relative-pos"
      },
      "found-by":"binding3",
      "sentence":"sent-PMC2828913-UAZ-r1-75-3",
      "verbose-text":"Although binding of VEGFR2 to beta3 integrin has been described                                                          , an association between beta1 integrins and VEGFR2 has been tested but not found .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "is-hypothesis":true,
      "frame-id":"evem-PMC2828913-UAZ-r1-75-1-121",
      "text":"matrix-bound VEGF",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-75-1-705"
        },
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-75-1-706"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-75",
        "offset":254,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-75",
        "offset":237,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-75-1",
      "found-by":"binding_token_3",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"We considered that integrins might play a role in the case of matrix bound VEGF , as the presence of matrix proteins would naturally mediate integrin engagement ."
    },
    {
      "text":"association between beta1 integrins and VEGFR2",
      "frame-id":"evem-PMC2828913-UAZ-r1-75-3-122",
      "arguments":[
        {
          "text":"beta1 integrins",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-75-3-712"
        },
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-75-3-713"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-75",
        "offset":588,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-75",
        "offset":542,
        "object-type":"relative-pos"
      },
      "found-by":"binding11",
      "sentence":"sent-PMC2828913-UAZ-r1-75-3",
      "verbose-text":"Although binding of VEGFR2 to beta3 integrin has been described                                                          , an association between beta1 integrins and VEGFR2 has been tested but not found .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-76-1-123",
      "text":"cadherins suppresses VEGFR2",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controlled",
          "arg":"ment-PMC2828913-UAZ-r1-76-1-730"
        },
        {
          "text":"cadherins",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controller",
          "arg":"ment-PMC2828913-UAZ-r1-76-1-729"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-76",
        "offset":210,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-76",
        "offset":183,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-76-1",
      "found-by":"Negative_activation_syntax_1_verb",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"In the case of VE-cadherin , it has been noted that clustering of cadherins suppresses VEGFR2 activation by reducing receptor internalization and activation within endocytosed vesicles                          ."
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-76-5-124",
      "text":"VEGFR2 phosphorylation",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-76-5-741"
        }
      ],
      "type":"protein-modification",
      "frame-type":"event-mention",
      "subtype":"phosphorylation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-76",
        "offset":976,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-76",
        "offset":954,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-76-5",
      "found-by":"Phosphorylation_syntax_4_noun",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"Thus , putting these results together it appears that neuropilins and beta1 integrins facilitate and enhance VEGFR2 activation , whereas clustering and engagement of VE-cadherin suppresses VEGFR2 phosphorylation but promotes capillary morphogenesis and vascular maturation ."
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-76-3-125",
      "text":"phosphorylates MLC2",
      "arguments":[
        {
          "text":"MLC2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-76-3-734"
        }
      ],
      "type":"protein-modification",
      "frame-type":"event-mention",
      "subtype":"phosphorylation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-76",
        "offset":497,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-76",
        "offset":478,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-76-3",
      "found-by":"Phosphorylation_syntax_1_verb",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"Consistent with this role , more recently it has been found that VE-cadherin phosphorylates MLC2 , leading to suppression of sprouting                       ."
    },
    {
      "text":"matrix-bound VEGF",
      "frame-id":"evem-PMC2828913-UAZ-r1-77-0-126",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-77-0-742"
        },
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-77-0-743"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-77",
        "offset":55,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-77",
        "offset":38,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-77-0",
      "verbose-text":"Another interesting effect found with matrix bound VEGF was induction of receptor clustering .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-77-1-127",
      "text":"VEGF induced a rapid movement of VEGFR2",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controlled",
          "arg":"ment-PMC2828913-UAZ-r1-77-1-745"
        },
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controller",
          "arg":"ment-PMC2828913-UAZ-r1-77-1-744"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-77",
        "offset":156,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-77",
        "offset":117,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-77-1",
      "found-by":"Positive_activation_syntax_1_verb",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"Both bound and soluble VEGF induced a rapid movement of VEGFR2 receptors from the center to the cell periphery ."
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-77-1-128",
      "text":"VEGF induced a rapid movement of VEGFR2 receptors",
      "arguments":[
        {
          "text":"VEGFR2 receptors",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controlled",
          "arg":"ment-PMC2828913-UAZ-r1-77-1-746"
        },
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controller",
          "arg":"ment-PMC2828913-UAZ-r1-77-1-744"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-77",
        "offset":166,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-77",
        "offset":117,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-77-1",
      "found-by":"Positive_activation_syntax_1_verb",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"Both bound and soluble VEGF induced a rapid movement of VEGFR2 receptors from the center to the cell periphery ."
    },
    {
      "text":"Matrix-bound (Vb",
      "frame-id":"evem-PMC2828913-UAZ-r1-86-0-129",
      "arguments":[
        {
          "text":"Matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-86-0-823"
        },
        {
          "text":"Vb",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-86-0-824"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-86",
        "offset":16,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-86",
        "offset":0,
        "object-type":"relative-pos"
      },
      "found-by":"binding1b",
      "sentence":"sent-PMC2828913-UAZ-r1-86-0",
      "verbose-text":"Matrix bound ( Vb ) and soluble ( Vs ) VEGF165 preparation",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"matrix-bound VEGF165",
      "frame-id":"evem-PMC2828913-UAZ-r1-87-5-130",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-87-5-832"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-87-5-833"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-87",
        "offset":617,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-87",
        "offset":597,
        "object-type":"relative-pos"
      },
      "found-by":"binding1b",
      "sentence":"sent-PMC2828913-UAZ-r1-87-5",
      "verbose-text":"Soluble VEGF165 was diluted into 1x PBS into same concentration as matrix bound VEGF165 and used as is .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "is-hypothesis":true,
      "frame-id":"evem-PMC2828913-UAZ-r1-87-0-131",
      "text":"matrix-bound VEGF",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-87-0-826"
        },
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-87-0-827"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-87",
        "offset":29,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-87",
        "offset":12,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-87-0",
      "found-by":"binding_token_3",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"To generate matrix bound VEGF ( Vb ) , indicated concentrations of the growth factor ( different isoforms as indicated ) were mixed with neutralized Purecol collagen gel ( 3.0 mg and ml ; Advanced Biomatrix ) and allowed to polymerize at 37degreesC for 1 h on plastic wrap ."
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-88-4-132",
      "text":"phosphorylation of VEGFR2",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-88-4-838"
        }
      ],
      "type":"protein-modification",
      "frame-type":"event-mention",
      "subtype":"phosphorylation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-88",
        "offset":562,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-88",
        "offset":537,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-88-4",
      "found-by":"Phosphorylation_syntax_1_noun",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"The cells were then collected and phosphorylation of VEGFR2 was determined as described below ."
    },
    {
      "text":"collagen-bound VEGF",
      "frame-id":"evem-PMC2828913-UAZ-r1-91-0-133",
      "arguments":[
        {
          "text":"collagen",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-91-0-848"
        },
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-91-0-849"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-91",
        "offset":90,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-91",
        "offset":71,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-91-0",
      "verbose-text":"To determine the release of VEGF from polymerized matrix gels , 2 ml of collagen bound VEGF was allowed to polymerize in a 50-ml falcon tube .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"collagen-bound VEGF",
      "frame-id":"evem-PMC2828913-UAZ-r1-92-0-134",
      "arguments":[
        {
          "text":"collagen",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-92-0-857"
        },
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-92-0-858"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-92",
        "offset":97,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-92",
        "offset":78,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-92-0",
      "verbose-text":"To indirectly assess the amount of VEGF retained in the collagen gel , 2 ml of collagen bound VEGF was polymerized in one 35-mm well , washed with 4 ml of 1x PBS , and the concentration of VEGF in each wash was measured by ELISA .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"VEGF bound to matrix",
      "frame-id":"evem-PMC2828913-UAZ-r1-93-2-135",
      "arguments":[
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-93-2-868"
        },
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-93-2-869"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-93",
        "offset":272,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-93",
        "offset":252,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-93-2",
      "verbose-text":"To measure the levels of VEGF bound to matrix , gels were placed on ice for 30 min to depolymerize and then either mixed with Laemmli buffer and boiled for 10 min for Western blot or diluted 50 times into sample buffer for ELISA analysis .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"bound VEGF, or collagen",
      "frame-id":"evem-PMC2828913-UAZ-r1-103-0-136",
      "arguments":[
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-103-0-911"
        },
        {
          "text":"collagen",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-103-0-912"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-103",
        "offset":178,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-103",
        "offset":155,
        "object-type":"relative-pos"
      },
      "found-by":"binding1a",
      "sentence":"sent-PMC2828913-UAZ-r1-103-0",
      "verbose-text":"HUVECs grown on Labtek chamberslides ( Thermo Fisher Scientific ) were starved for 6 h and incubated in the presence or absence of soluble VEGF ( 200 ng and ml ) , bound VEGF , or collagen alone for 20 min .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-119-3-137",
      "text":"p38 phosphorylation",
      "arguments":[
        {
          "text":"p38",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-119-3-955"
        }
      ],
      "type":"protein-modification",
      "frame-type":"event-mention",
      "subtype":"phosphorylation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-119",
        "offset":407,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-119",
        "offset":388,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-119-3",
      "found-by":"Phosphorylation_syntax_4_noun",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"The level of p38 phosphorylation was determined with the cell based phospho-p38 ELISA kit ( RayBiotech ) ."
    },
    {
      "text":"matrix-bound VEGF",
      "frame-id":"evem-PMC2828913-UAZ-r1-122-5-138",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-122-5-970"
        },
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-122-5-971"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-122",
        "offset":443,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-122",
        "offset":426,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-122-5",
      "verbose-text":"It also shows an ELISA VEGFR2 detection system that provides additional independent support to the fact that matrix bound VEGF can activate VEGFR2 .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-122-12-139",
      "text":"matrix metalloproteinase-resistant VEGF mutants also induce activation of VEGFR2",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controlled",
          "arg":"ment-PMC2828913-UAZ-r1-122-12-990"
        },
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controller",
          "arg":"ment-PMC2828913-UAZ-r1-122-12-988"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-122",
        "offset":1044,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-122",
        "offset":964,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-122-12",
      "found-by":"Positive_activation_syntax_1_verb",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"S4 shows presentation of VEGF using a solid phase assay and demonstrates that matrix metalloproteinase resistant VEGF mutants also induce activation of VEGFR2 and p38 ."
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-122-12-140",
      "text":"matrix metalloproteinase-resistant VEGF mutants also induce activation of VEGFR2 and p38",
      "arguments":[
        {
          "text":"p38",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controlled",
          "arg":"ment-PMC2828913-UAZ-r1-122-12-991"
        },
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controller",
          "arg":"ment-PMC2828913-UAZ-r1-122-12-988"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-122",
        "offset":1052,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-122",
        "offset":964,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-122-12",
      "found-by":"Positive_activation_syntax_1_verb",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"S4 shows presentation of VEGF using a solid phase assay and demonstrates that matrix metalloproteinase resistant VEGF mutants also induce activation of VEGFR2 and p38 ."
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-122-12-141",
      "text":"VEGF mutants also induce activation of VEGFR2",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controlled",
          "arg":"ment-PMC2828913-UAZ-r1-122-12-990"
        },
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controller",
          "arg":"ment-PMC2828913-UAZ-r1-122-12-989"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-122",
        "offset":1044,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-122",
        "offset":999,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-122-12",
      "found-by":"Positive_activation_syntax_1_verb",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"S4 shows presentation of VEGF using a solid phase assay and demonstrates that matrix metalloproteinase resistant VEGF mutants also induce activation of VEGFR2 and p38 ."
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-122-12-142",
      "text":"VEGF mutants also induce activation of VEGFR2 and p38",
      "arguments":[
        {
          "text":"p38",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controlled",
          "arg":"ment-PMC2828913-UAZ-r1-122-12-991"
        },
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controller",
          "arg":"ment-PMC2828913-UAZ-r1-122-12-989"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-122",
        "offset":1052,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-122",
        "offset":999,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-122-12",
      "found-by":"Positive_activation_syntax_1_verb",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"S4 shows presentation of VEGF using a solid phase assay and demonstrates that matrix metalloproteinase resistant VEGF mutants also induce activation of VEGFR2 and p38 ."
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-122-6-143",
      "text":"phosphorylation of VEGFR2",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-122-6-974"
        }
      ],
      "type":"protein-modification",
      "frame-type":"event-mention",
      "subtype":"phosphorylation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-122",
        "offset":575,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-122",
        "offset":550,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-122-6",
      "found-by":"Phosphorylation_syntax_1_noun",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"The figure further illustrates that presence of protease inhibitors does not prevent phosphorylation of VEGFR2 by matrix bound VEGF ."
    },
    {
      "text":"matrix-bound VEGF",
      "frame-id":"evem-PMC2828913-UAZ-r1-122-6-144",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-122-6-975"
        },
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-122-6-976"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-122",
        "offset":596,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-122",
        "offset":579,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-122-6",
      "verbose-text":"The figure further illustrates that presence of protease inhibitors does not prevent phosphorylation of VEGFR2 by matrix bound VEGF .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"matrix-bound VEGF",
      "frame-id":"evem-PMC2828913-UAZ-r1-122-2-145",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-122-2-962"
        },
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-122-2-963"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-122",
        "offset":203,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-122",
        "offset":186,
        "object-type":"relative-pos"
      },
      "found-by":"binding_syntax_23_verb",
      "sentence":"sent-PMC2828913-UAZ-r1-122-2",
      "verbose-text":"It also compares the half-life of soluble and matrix bound VEGF .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-122-4-146",
      "text":"VEGFR2 phosphorylation",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-122-4-966"
        }
      ],
      "type":"protein-modification",
      "frame-type":"event-mention",
      "subtype":"phosphorylation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-122",
        "offset":274,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-122",
        "offset":252,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-122-4",
      "found-by":"Phosphorylation_syntax_4_noun",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"S2 demonstrates densitometric analysis of VEGFR2 phosphorylation induced by soluble and matrix bound VEGF ."
    },
    {
      "text":"matrix-bound VEGF",
      "frame-id":"evem-PMC2828913-UAZ-r1-122-4-147",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-122-4-967"
        },
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-122-4-968"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-122",
        "offset":315,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-122",
        "offset":298,
        "object-type":"relative-pos"
      },
      "found-by":"binding1b",
      "sentence":"sent-PMC2828913-UAZ-r1-122-4",
      "verbose-text":"S2 demonstrates densitometric analysis of VEGFR2 phosphorylation induced by soluble and matrix bound VEGF .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"matrix-bound VEGF",
      "frame-id":"evem-PMC2828913-UAZ-r1-122-5-148",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-122-5-970"
        },
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-122-5-971"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-122",
        "offset":443,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-122",
        "offset":426,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-122-5",
      "verbose-text":"It also shows an ELISA VEGFR2 detection system that provides additional independent support to the fact that matrix bound VEGF can activate VEGFR2 .",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-122-5-149",
      "text":"matrix-bound VEGF can activate VEGFR2",
      "arguments":[
        {
          "text":"VEGFR2",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controlled",
          "arg":"ment-PMC2828913-UAZ-r1-122-5-972"
        },
        {
          "text":"matrix-bound VEGF",
          "argument-type":"complex",
          "object-type":"argument",
          "index":0,
          "argument-label":"controller",
          "args":{
            "theme1":"ment-PMC2828913-UAZ-r1-122-5-970",
            "theme2":"ment-PMC2828913-UAZ-r1-122-5-971"
          }
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-122",
        "offset":463,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-122",
        "offset":426,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-122-5",
      "found-by":"Positive_activation_syntax_1_verb",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"It also shows an ELISA VEGFR2 detection system that provides additional independent support to the fact that matrix bound VEGF can activate VEGFR2 ."
    },
    {
      "text":"Vb matrix-bound VEGF VEGFR VEGF receptor Vs soluble VEGF",
      "frame-id":"evem-PMC2828913-UAZ-r1-125-0-150",
      "arguments":[
        {
          "text":"Vb",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-125-0-1009"
        },
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-125-0-1014"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-125",
        "offset":135,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-125",
        "offset":79,
        "object-type":"relative-pos"
      },
      "found-by":"binding1b",
      "sentence":"sent-PMC2828913-UAZ-r1-125-0",
      "verbose-text":"Abbreviations used in this paper : HUVEC human umbilical vein endothelial cells Vb matrix bound VEGF VEGFR VEGF receptor Vs soluble VEGF",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"matrix-bound VEGF",
      "frame-id":"evem-PMC2828913-UAZ-r1-125-0-151",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-125-0-1010"
        },
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-125-0-1011"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-125",
        "offset":99,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-125",
        "offset":82,
        "object-type":"relative-pos"
      },
      "found-by":"binding_token_3",
      "sentence":"sent-PMC2828913-UAZ-r1-125-0",
      "verbose-text":"Abbreviations used in this paper : HUVEC human umbilical vein endothelial cells Vb matrix bound VEGF VEGFR VEGF receptor Vs soluble VEGF",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "text":"matrix-bound VEGF",
      "frame-id":"evem-PMC2828913-UAZ-r1-128-0-152",
      "arguments":[
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-128-0-1015"
        },
        {
          "text":"VEGF",
          "argument-type":"entity",
          "object-type":"argument",
          "index":1,
          "argument-label":"theme",
          "arg":"ment-PMC2828913-UAZ-r1-128-0-1016"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-128",
        "offset":17,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-128",
        "offset":0,
        "object-type":"relative-pos"
      },
      "found-by":"binding1b",
      "sentence":"sent-PMC2828913-UAZ-r1-128-0",
      "verbose-text":"matrix bound VEGF",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      }
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-18-2-153",
      "text":"matrix-bound VEGF165 induced phosphorylation of VEGFR2",
      "arguments":[
        {
          "text":"phosphorylation of VEGFR2",
          "argument-type":"event",
          "object-type":"argument",
          "index":0,
          "argument-label":"controlled",
          "arg":"evem-PMC2828913-UAZ-r1-18-2-18"
        },
        {
          "text":"matrix-bound VEGF165",
          "argument-type":"complex",
          "object-type":"argument",
          "index":0,
          "argument-label":"controller",
          "args":{
            "theme1":"ment-PMC2828913-UAZ-r1-18-2-117",
            "theme2":"ment-PMC2828913-UAZ-r1-18-2-118"
          }
        }
      ],
      "type":"regulation",
      "frame-type":"event-mention",
      "subtype":"positive-regulation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-18",
        "offset":372,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-18",
        "offset":318,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-18-2",
      "found-by":"Positive_regulation_syntax_1_verb",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"We found that matrix bound VEGF165 induced phosphorylation of VEGFR2 at equivalent levels as of soluble VEGF165 at 5 min                      ."
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-18-6-154",
      "text":"matrix-bound VEGF165 than soluble VEGF165 were sufficient to induce phosphorylation of VEGFR2",
      "arguments":[
        {
          "text":"phosphorylation of VEGFR2",
          "argument-type":"event",
          "object-type":"argument",
          "index":0,
          "argument-label":"controlled",
          "arg":"evem-PMC2828913-UAZ-r1-18-6-21"
        },
        {
          "text":"matrix-bound VEGF165",
          "argument-type":"complex",
          "object-type":"argument",
          "index":0,
          "argument-label":"controller",
          "args":{
            "theme1":"ment-PMC2828913-UAZ-r1-18-6-130",
            "theme2":"ment-PMC2828913-UAZ-r1-18-6-131"
          }
        }
      ],
      "type":"regulation",
      "frame-type":"event-mention",
      "subtype":"positive-regulation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-18",
        "offset":1042,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-18",
        "offset":949,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-18-6",
      "found-by":"Positive_regulation_syntax_1_verb",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"Furthermore , lower concentrations of matrix bound VEGF165 than soluble VEGF165 were sufficient to induce phosphorylation of VEGFR2           ."
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-20-0-155",
      "text":"VEGF165 is able to phosphorylate VEGFR2",
      "arguments":[
        {
          "text":"phosphorylate VEGFR2",
          "argument-type":"event",
          "object-type":"argument",
          "index":0,
          "argument-label":"controlled",
          "arg":"evem-PMC2828913-UAZ-r1-20-0-31"
        },
        {
          "text":"VEGF165",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controller",
          "arg":"ment-PMC2828913-UAZ-r1-20-0-137"
        }
      ],
      "type":"regulation",
      "frame-type":"event-mention",
      "subtype":"positive-regulation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-20",
        "offset":52,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-20",
        "offset":13,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-20-0",
      "found-by":"Phosphorylation_syntax_1_verb",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"Matrix bound VEGF165 is able to phosphorylate VEGFR2 ."
    },
    {
      "is-hypothesis":true,
      "frame-id":"evem-PMC2828913-UAZ-r1-20-7-156",
      "text":"VEGFR2 phosphorylation was induced by different concentrations of Vs",
      "arguments":[
        {
          "text":"VEGFR2 phosphorylation",
          "argument-type":"event",
          "object-type":"argument",
          "index":0,
          "argument-label":"controlled",
          "arg":"evem-PMC2828913-UAZ-r1-20-7-27"
        },
        {
          "text":"Vs",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controller",
          "arg":"ment-PMC2828913-UAZ-r1-20-7-150"
        }
      ],
      "type":"regulation",
      "frame-type":"event-mention",
      "subtype":"positive-regulation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-20",
        "offset":811,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-20",
        "offset":743,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-20-7",
      "found-by":"Positive_regulation_syntax_2_verb",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"( D ) VEGFR2 phosphorylation was induced by different concentrations of Vs or Vb , as indicated ."
    },
    {
      "is-hypothesis":true,
      "frame-id":"evem-PMC2828913-UAZ-r1-20-7-157",
      "text":"VEGFR2 phosphorylation was induced by different concentrations of Vs or Vb",
      "arguments":[
        {
          "text":"VEGFR2 phosphorylation",
          "argument-type":"event",
          "object-type":"argument",
          "index":0,
          "argument-label":"controlled",
          "arg":"evem-PMC2828913-UAZ-r1-20-7-27"
        },
        {
          "text":"Vb",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controller",
          "arg":"ment-PMC2828913-UAZ-r1-20-7-151"
        }
      ],
      "type":"regulation",
      "frame-type":"event-mention",
      "subtype":"positive-regulation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-20",
        "offset":817,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-20",
        "offset":743,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-20-7",
      "found-by":"Positive_regulation_syntax_2_verb",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"( D ) VEGFR2 phosphorylation was induced by different concentrations of Vs or Vb , as indicated ."
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-48-7-158",
      "text":"VEGFR2 phosphorylation kinetics induced by Vb",
      "arguments":[
        {
          "text":"VEGFR2 phosphorylation",
          "argument-type":"event",
          "object-type":"argument",
          "index":0,
          "argument-label":"controlled",
          "arg":"evem-PMC2828913-UAZ-r1-48-7-74"
        },
        {
          "text":"Vb",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controller",
          "arg":"ment-PMC2828913-UAZ-r1-48-7-440"
        }
      ],
      "type":"regulation",
      "frame-type":"event-mention",
      "subtype":"positive-regulation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-48",
        "offset":1214,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-48",
        "offset":1169,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-48-7",
      "found-by":"Positive_regulation_syntax_2_verb",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"Therefore , the differences in VEGFR2 phosphorylation kinetics induced by Vb were not the product of changes in VEGF stability ."
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-59-2-159",
      "text":"phosphorylation of VEGFR2-Y1214 induced by matrix-bound VEGF165",
      "arguments":[
        {
          "text":"phosphorylation of VEGFR2-Y1214",
          "argument-type":"event",
          "object-type":"argument",
          "index":0,
          "argument-label":"controlled",
          "arg":"evem-PMC2828913-UAZ-r1-59-2-88"
        },
        {
          "text":"matrix-bound VEGF165",
          "argument-type":"complex",
          "object-type":"argument",
          "index":0,
          "argument-label":"controller",
          "args":{
            "theme1":"ment-PMC2828913-UAZ-r1-59-2-532",
            "theme2":"ment-PMC2828913-UAZ-r1-59-2-533"
          }
        }
      ],
      "type":"regulation",
      "frame-type":"event-mention",
      "subtype":"positive-regulation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-59",
        "offset":428,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-59",
        "offset":365,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-59-2",
      "found-by":"Positive_regulation_syntax_2_verb",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"Furthermore , prolonged phosphorylation of VEGFR2-Y1214 induced by matrix bound VEGF165 at 15 min was no longer detected if the cells were pretreated with beta1 integrin inhibitory antibodies           ."
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-75-5-160",
      "text":"matrix-bound VEGF significantly increased the ratio of beta1 integrin associated with activated VEGFR2",
      "arguments":[
        {
          "text":"beta1 integrin associated with activated VEGFR2",
          "argument-type":"event",
          "object-type":"argument",
          "index":0,
          "argument-label":"controlled",
          "arg":"evem-PMC2828913-UAZ-r1-75-5-117"
        },
        {
          "text":"matrix-bound VEGF",
          "argument-type":"complex",
          "object-type":"argument",
          "index":0,
          "argument-label":"controller",
          "args":{
            "theme1":"ment-PMC2828913-UAZ-r1-75-5-715",
            "theme2":"ment-PMC2828913-UAZ-r1-75-5-716"
          }
        }
      ],
      "type":"regulation",
      "frame-type":"event-mention",
      "subtype":"positive-regulation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-75",
        "offset":881,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-75",
        "offset":779,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-75-5",
      "found-by":"Positive_regulation_syntax_1_verb",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"Nonetheless , we found that matrix bound VEGF significantly increased the ratio of beta1 integrin associated with activated VEGFR2 in a time dependent manner , with maximum phosphorylation at 15 min and still clearly detectable by 30 min ."
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-76-3-161",
      "text":"VE-cadherin phosphorylates MLC2",
      "arguments":[
        {
          "text":"phosphorylates MLC2",
          "argument-type":"event",
          "object-type":"argument",
          "index":0,
          "argument-label":"controlled",
          "arg":"evem-PMC2828913-UAZ-r1-76-3-125"
        },
        {
          "text":"VE-cadherin",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controller",
          "arg":"ment-PMC2828913-UAZ-r1-76-3-733"
        }
      ],
      "type":"regulation",
      "frame-type":"event-mention",
      "subtype":"positive-regulation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-76",
        "offset":497,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-76",
        "offset":466,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-76-3",
      "found-by":"Phosphorylation_syntax_1_verb",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"Consistent with this role , more recently it has been found that VE-cadherin phosphorylates MLC2 , leading to suppression of sprouting                       ."
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-76-5-162",
      "text":"VE-cadherin suppresses VEGFR2 phosphorylation",
      "arguments":[
        {
          "text":"VEGFR2 phosphorylation",
          "argument-type":"event",
          "object-type":"argument",
          "index":0,
          "argument-label":"controlled",
          "arg":"evem-PMC2828913-UAZ-r1-76-5-124"
        },
        {
          "text":"VE-cadherin",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controller",
          "arg":"ment-PMC2828913-UAZ-r1-76-5-740"
        }
      ],
      "type":"regulation",
      "frame-type":"event-mention",
      "subtype":"negative-regulation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-76",
        "offset":976,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-76",
        "offset":931,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-76-5",
      "found-by":"Negative_regulation_syntax_1_verb",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"Thus , putting these results together it appears that neuropilins and beta1 integrins facilitate and enhance VEGFR2 activation , whereas clustering and engagement of VE-cadherin suppresses VEGFR2 phosphorylation but promotes capillary morphogenesis and vascular maturation ."
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-122-6-163",
      "text":"protease inhibitors does not prevent phosphorylation of VEGFR2",
      "arguments":[
        {
          "text":"phosphorylation of VEGFR2",
          "argument-type":"event",
          "object-type":"argument",
          "index":0,
          "argument-label":"controlled",
          "arg":"evem-PMC2828913-UAZ-r1-122-6-143"
        },
        {
          "text":"protease",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controller",
          "arg":"ment-PMC2828913-UAZ-r1-122-6-973"
        }
      ],
      "type":"regulation",
      "frame-type":"event-mention",
      "subtype":"positive-regulation",
      "is-negated":true,
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-122",
        "offset":575,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-122",
        "offset":513,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-122-6",
      "found-by":"Negative_regulation_syntax_1_verb",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"The figure further illustrates that presence of protease inhibitors does not prevent phosphorylation of VEGFR2 by matrix bound VEGF ."
    },
    {
      "frame-id":"evem-PMC2828913-UAZ-r1-122-6-164",
      "text":"phosphorylation of VEGFR2 by matrix",
      "arguments":[
        {
          "text":"phosphorylation of VEGFR2",
          "argument-type":"event",
          "object-type":"argument",
          "index":0,
          "argument-label":"controlled",
          "arg":"evem-PMC2828913-UAZ-r1-122-6-143"
        },
        {
          "text":"matrix",
          "argument-type":"entity",
          "object-type":"argument",
          "index":0,
          "argument-label":"controller",
          "arg":"ment-PMC2828913-UAZ-r1-122-6-975"
        }
      ],
      "type":"regulation",
      "frame-type":"event-mention",
      "subtype":"positive-regulation",
      "end-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-122",
        "offset":585,
        "object-type":"relative-pos"
      },
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC2828913-UAZ-r1-122",
        "offset":550,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC2828913-UAZ-r1-122-6",
      "found-by":"Phosphorylation_syntax_1_noun",
      "object-meta":{
        "component":"REACH",
        "object-type":"meta-info"
      },
      "verbose-text":"The figure further illustrates that presence of protease inhibitors does not prevent phosphorylation of VEGFR2 by matrix bound VEGF ."
    }
  ],
  "object-type":"frame-collection",
  "object-meta":{
    "processing-end":"2015-06-14T21:43:54Z",
    "doc-id":"PMC2828913",
    "component-type":"machine",
    "component":"REACH",
    "processing-start":"2015-06-14T21:40:56Z",
    "object-type":"meta-info",
    "organization":"UAZ"
  }
}
